简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2023-09-27 09:00 Medisca Takes Steps to Protect its Innovative Technologies
2023-09-27 08:28 Elpiscience Announces First Patient Dosed for Phase 1 Clinical Trial of Anti-LILRB2 Antibody ES009 in Australia
2023-09-26 17:58 Takeda Announces Approval of CUVITRU™ Subcutaneous Immunoglobulin in Japan for Patients with Agammaglobulinemia or Hypogammaglobulinemia
2023-09-25 18:51 Aster Guardians Global Nursing Award 2024 is Now Open for Entry Worldwide, One Nurse Will Win the US $250,000 Award
2023-09-25 11:15 Kenvue to Announce Third Quarter 2023 Results on October 26, 2023
2023-09-22 10:29 ReNAgade Therapeutics Named to the 2023 Endpoints 11
2023-09-21 08:47 MRM Health Reports Positive Topline Results from Phase 2a Clinical Study with MH002 in Mild-to-Moderate Ulcerative Colitis
2023-09-20 15:35 Julie Gerardi Joins Parse Biosciences as Vice President of Business Development
2023-09-20 15:06 Blood Cancer: AOP Health Announces New Findings in Patients With Polycythemia Vera Published in Medical Journal Leukemia
2023-09-20 11:05 “Too Much Time Has Been Wasted”: PMI CEO Challenges Governments Across the Globe to Embrace Smoke-Free Alternatives to End Cigarettes Faster
2023-09-19 19:24 Recharge Capital Taps Bridgewater Associates Singapore Executive Margaret Wang as Managing Partner
2023-09-19 09:42 Pharmanovia Acquires Global Central Nervous System (CNS) Portfolio From Sanofi
2023-09-15 10:15 Biocytogen Officially Launches RenMice® Series
2023-09-14 18:33 Boehringer Ingelheim receives SBTi validation for CO2 reduction targets
2023-09-14 10:53 Ahead of UN General Assembly, pharmaceutical industry underscores need for pandemic preparedness plans to support innovation and equity
2023-09-13 10:11 ReNAgade Therapeutics Appoints Laurie Stelzer as Chief Financial Officer
2023-09-13 09:54 KBI Biopharma, Inc. Expands Global Portfolio with Launch of SUREmAb™ for Faster Monoclonal Antibody Development and Manufacturing
2023-09-12 09:53 Monrol Announces Investment to Expand its n.c.a. Lu-177 Production Capacity
2023-09-12 09:34 SINOVAC Reports on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection
2023-09-11 18:58 Takeda Announces Positive Topline Results from Phase 2b Study Evaluating TAK-279, a Highly Selective Oral TYK2 Inhibitor, for the Treatment of Active Psoriatic Arthritis